UroGen Pharma Ltd. ( URGN) - Stock Earnings
URGN Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 6, 2026, midnight | — / — | — | — / — | — |
URGN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -33.3 million USD | 27.5 million USD |
| 2025Q4 | -26.4 million USD | 37.8 million USD |
| 2026Q1 | -23.6 million USD | 51.0 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
URGN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -102.2 million USD | 82.7 million USD |
| 2024 | -126.9 million USD | 90.4 million USD |
| 2025 | -153.5 million USD | 109.8 million USD |
| 2026 Est. | — | — |
URGN
Price: $40.97
52 week price:
Earnings Per Share: -2.74 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 20983
Ebitda: -286000Market Capitalization: 1.9 billion